Allergic Conjunctivitis (AC) affects 15-20% of the worldwide population. Environmental exposure chamber (EEC) may facilitate clinical trials as it mimics natural allergen exposure, in a controlled setting which may aid in the selection of adequately allergic AC subjects. To read this article in full you will need to make a payment ACAAI Member Login ACAAI Member, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.